Recently, Sjaak Bloem and I had the privilege of presenting the BEAMER project to the Dutch CRO community during the annual Association of Contract Research Organization Netherlands (ACRON) symposium. The event, overseen by Prof. Dr. Carmen Dirksen of Maastricht University, centered around patient participation in clinical studies—a focal point that aligns closely with BEAMER’s overarching vision.
Enhancing patient participation has been a core aspect of BEAMER’s mission, woven into the project’s framework. Beyond conducting extensive patient surveys, patients are active collaborators at every stage. Their involvement spans individual interactions through interviews and Delphi sessions, representation via project partners like APDP, AISM, and the World Duchenne Organization, as well as through our Patient Advisory Board.
Our fundamental belief is simple: genuine patient engagement begins with a comprehensive understanding of patients, a milestone we aim to achieve through BEAMER.
Particularly noteworthy were the presentations by Prof. Dr. Astrid Janssens from Utrecht University and Dr. Evelyn van der Aa of the Centrale Commissie Mensgebonden Onderzoek (CCMO), the governmental body responsible for reviewing and approving medical research involving human subjects.
Prof. Dr. Astrid Janssens eloquently advocated for the equal involvement of patients and caregivers in clinical research. Emphasizing equivalence is crucial, as it necessitates adjusted communication strategies. Often, there exists not only a knowledge gap between healthcare providers and patients/caregivers but also differing perceptions.
This discrepancy poses a risk of losing valuable insights during communication. Notably, she highlighted the role of caregivers—an often-overlooked aspect in discussions centered solely on patient participation. Drawing from her involvement in a UK study, she emphasized the vital information caregivers can provide and their need for support during a patient’s treatment journey.
As part of their patient participation initiative, CCMO is formulating new guidelines and regulations to bolster the role of patients in designing and executing clinical study protocols. While patient participation isn’t currently mandatory, CCMO is progressing towards full integration into studies in the Netherlands. Effective 1st March 2023, studies in the Netherlands must substantiate their inclusion or exclusion of patient participation. Full integration promises numerous benefits: patients gain clearer study information, contribute to protocol alignment, and receive regular updates on study progress and outcomes. For research organisations, this integration streamlines protocol approvals and grant acquisition, facilitating patient inclusion and retention while reducing research costs and delays—ultimately benefitting society by aligning research outcomes with real-world needs.
As Bob Dylan famously sang, “The times they are a-changin’,” and indeed, patients’ and caregivers’ roles in clinical studies are evolving. Their insights, needs, and challenges will reshape the landscape of clinical research, necessitating enhanced support—an area where BEAMER stands poised to offer expertise, knowledge, and guidelines to drive this transformation into reality. The information shared by Sjaak and me about BEAMER and the SHE model garnered keen interest, sparking numerous inquiries about real-world implementation. ACRON eagerly anticipates our further insights at their upcoming annual symposium.
About the author:
Aad R. Liefveld, Link2Trials, (BEAMER’s Work Package 1 Co-Lead)
Feel free to share your thoughts by contacting us
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)
It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.
These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.
Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.
The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.
The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.
“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”